A Cannabis Break Guide’s Completion Rate Does Not Establish Its Treatment Effect
Young adults who used a cannabis-break guide heavily were more likely to report completing a 21-day break. The pilot supports feasibility, but its design cannot determine how much the guide itself caused that difference.
A voluntary guide, not randomized treatment
The study analyzed 125 participants aged 18–29. Everyone was invited to attempt a 21-day cannabis break and consider using an online guide with daily reflections, activities and encouragement. Participants completed baseline and approximately 30-day follow-up surveys.
Guide use was voluntary. Researchers classified participants by their later report of no use, some use or a lot of use. There was no randomized control group, and the study did not verify cannabis abstinence with blood, urine, oral-fluid or other toxicology.
What the reported percentages mean
Overall, 77 participants, approximately 62%, reported completing the break. Completion was more common among those reporting a lot of guide use than among the other guide-use categories combined: 84% versus 54%. Other responses included plans for future breaks and changes in how participants described balanced cannabis use.
These are associations within a selected sample. Motivation, persistence and available support could influence both guide use and completion. Someone who completed a break may also remember or describe their engagement with the guide differently.
A practical resource still needs an efficacy trial
The pilot can show that recruitment, distribution and follow-up are workable. It also provides feedback on which guide components participants found useful. Those contributions differ from an estimate of benefit relative to an otherwise comparable group without the guide.
The sample was largely recruited through university-related channels and an online cannabis forum. Self-selection, self-report, small sample size and short follow-up limit generalization. The findings do not establish durable treatment of cannabis use disorder.
Nor did a 21-day target validate biological tolerance reversal or a drug-testing clearance period. The study measured reported behavior, not receptor normalization, cannabinoid elimination or driving ability. Those claims would require different endpoints and evidence.
When assessing a promotional claim, ask whether the percentage describes all participants, heavy guide users or a randomized comparison. A high completion proportion can be encouraging while the causal treatment effect remains unknown.
Related analysis: evaluating cannabis tolerance claims.
Primary research
Fontana TJK; Schulz JA; Budney AJ; Villanti AC. Feasibility and utility of a structured guide for cannabis tolerance breaks in young adults. Journal of American college health : J of ACH (2025). DOI: 10.1080/07448481.2022.2155061.
